Table of Contents
Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis
Related Topics
Chronic Kidney Disease Market Size Chronic Kidney Disease (CKD) Drug Market Size Chronic Kidney Disease (CKD) Nutritional Supplements Market Size Cardiovascular Diagnostic and Monitoring Market SizeGlobal Chronic Kidney Disease Treatment Market Size to Exceed USD 47.99 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Chronic Kidney Disease Treatment Market Size is Expected to Grow from USD 33.20 Billion in 2023 to USD 47.99 Billion by 2033, at a CAGR of 3.75% during the forecast period 2023-2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Chronic Kidney Disease Treatment Market Size, Share, and COVID-19 Impact Analysis, By Treatment (Drugs [Type {Erythropoietic Stimulating agents, ACE Inhibitors, Diuretics, and Others}] and Dialysis [Type {Equipment and Consumables}), By End-User (Hospital, Dialysis Center, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
The chronic kidney disease (CKD) treatment market is defined as the world market involved in the manufacturing, production, and sale of medication, therapy, medical devices, and treatment remedies for treating chronic kidney disease. The market is composed of such pharmaceutical therapies as angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), diuretics, and phosphate binders, plus dialysis machinery, kidney transplantation services, and lifestyle management therapy. Furthermore, the global chronic kidney disease (CKD) treatment market is driven by the rising prevalence of diabetes and hypertension, aging populations, advancements in dialysis and transplant technologies, increasing healthcare expenditure, and growing awareness of early CKD diagnosis. Additionally, government initiatives, improved healthcare infrastructure, and novel drug developments further fuel market growth worldwide. However, the high treatment costs, limited organ donors for transplants, adverse drug effects, lack of awareness, and inadequate healthcare access in developing regions are key restraints for the growth of the market.
The drugs segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of the treatment, the global chronic kidney disease treatment market is divided into drugs and dialysis. The drugs segment is divided into type and the type segment is further divided into erythropoietic stimulating agents, ACE inhibitors, diuretics, and others. The dialysis segment is divided into type and the type segment is further divided into equipment and consumables. Among these, the drugs segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is expanded to the rising prevalence of CKD, increased adoption of pharmaceutical therapies like ACE inhibitors and SGLT2 inhibitors, and ongoing drug innovations. Growing awareness, improved accessibility to medications, and expanding government initiatives further drive demand, ensuring significant CAGR growth during the forecast period.
The hospital segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.
On the basis of the end-user, the global chronic kidney disease treatment market is divided into hospital, dialysis center, and others. Among these, the hospital segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segmental growth is attributed to the rising patient admissions, advanced healthcare infrastructure, and increasing demand for specialized treatments. Growth is driven by technological advancements, higher healthcare spending, and expanding hospital networks. Additionally, the prevalence of chronic diseases and aging populations further fuel the segment's remarkable CAGR.
North America is projected to hold the largest share of the global chronic kidney disease treatment market over the forecast period.
North America is projected to hold the largest share of the global chronic kidney disease treatment market over the forecast period. The regional growth is attributed to its advanced healthcare infrastructure, high prevalence of kidney disorders, and strong R&D investments. Favorable reimbursement policies, increasing awareness, and the presence of key pharmaceutical players further drive market growth, ensuring sustained dominance throughout the forecast period.
Asia Pacific is expected to grow at the fastest CAGR growth of the global chronic kidney disease treatment market during the forecast period. The regional growth is attributed to the rising disease prevalence, expanding healthcare access, and increasing government initiatives. Growing medical tourism, a large aging population, and higher investments in healthcare infrastructure further fuel market expansion, making the region a key driver of future growth.
Company Profiling
Major vendors in the global chronic kidney disease treatment market are Becton, Dickinson and Company, Fresenius SE and Co. KGaA, B. Braun SE, AstraZeneca plc, F. Hoffmann-La Roche Ltd., AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Johnson & Johnson, and others.
Key Target Audience
Recent Development
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global chronic kidney disease treatment market based on the below-mentioned segments:
Global Chronic Kidney Disease Treatment Market, By Treatment
Global Chronic Kidney Disease Treatment Market, By End-User
Global Chronic Kidney Disease Treatment Market, By Regional
May 2025 - The Global Chronic Kidney Disease Market Size is Expected to Grow from USD 38.30 Billion in 2023 to USD 66.65 Billion by 2033, at a CAGR of 5.70% during the forecast period 2023-2033
May 2025 - The Global Chronic Kidney Disease (CKD) Drug Market Size is Expected to Grow from USD 14.2 Billion in 2023 to USD 20.80 Billion by 2033, at a CAGR of 3.89% during the forecast period 2023-2033
May 2025 - The Global Chronic Kidney Disease (CKD) Nutritional Supplements Market Size is Expected to Grow from USD 3.56 Billion in 2023 to USD 5.20 Billion by 2033, at a CAGR of 3.86% during the forecast period 2023-2033
We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.
+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com
